IRADIMED CORP Quarterly Operating Income (Loss) in USD from Q2 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Iradimed Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q4 2024.
  • Iradimed Corp Operating Income (Loss) for the quarter ending December 31, 2024 was $5.8M, a 12.4% increase year-over-year.
  • Iradimed Corp Operating Income (Loss) for the twelve months ending December 31, 2024 was $22M, a 9.63% increase year-over-year.
  • Iradimed Corp annual Operating Income (Loss) for 2024 was $22M, a 9.63% increase from 2023.
  • Iradimed Corp annual Operating Income (Loss) for 2023 was $20M, a 28.2% increase from 2022.
  • Iradimed Corp annual Operating Income (Loss) for 2022 was $15.6M, a 59.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.